发明名称 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
摘要 PROBLEM TO BE SOLVED: To provide inhibitors of ATR (ATM and Rad3 related) protein kinase, which acts with ATM (ataxia telangiectasia mutated) kinase and many other proteins to regulate a cell's response to DNA damage, commonly referred to as the DNA damage response (DDR).SOLUTION: The present invention relates to pyrazine compounds of the formula I in the figure, or pharmaceutically acceptable salts thereof. (R1 is a 5-6 membered monocyclic aromatic or heteroaromatic ring having 0-4 heteroatoms selected from N, O and S; Ris -Q or -Q-Q; Q is a 3-7 membered monocyclic saturated or unsaturated non-aromatic ring having 0-4 heteroatoms selected from N, O and S; Qis a 3-8 membered monocyclic saturated or unsaturated ring having 0-4 heteroatoms selected from N, O and S; and Q and Qmay form a fused bicyclic ring).
申请公布号 JP2014240410(A) 申请公布日期 2014.12.25
申请号 JP20140165380 申请日期 2014.08.15
申请人 VERTEX PHARMACEUTICALS INC 发明人 CHARRIER JEAN-DAMIEN;STEVEN DURRANT;KAY DAVID;O'DONNELL MICHAEL;KNEGTEL RONALD;SOMHAIRLE MACCORMICK;JOANNE PINDER;ANISA NIZARALI VIRANI;YOUNG STEVEN;HALEY MARIE BINCH;THOMAS CLEVELAND;LEV T D FANNING;DENNIS J HURLEY;PRAMOD JOSHI;URVI SHETH;ALINA SILINA;PHILIP MICHAEL REAPER
分类号 C07D241/26;A61K31/497;A61K31/5377;A61K31/541;A61K31/551;A61K45/00;A61P1/16;A61P17/06;A61P31/12;A61P31/18;A61P35/00;A61P43/00;C07D401/12;C07D401/14;C07D403/04;C07D403/14;C07D405/14;C07D409/04;C07D409/14;C07D413/04;C07D413/14;C07D417/04;C07D417/14;C07D471/04;C07D487/04;C07D487/08;C07D487/10;C07D491/113;C07D513/04 主分类号 C07D241/26
代理机构 代理人
主权项
地址